Diabetes and percutaneous coronary revascularization in the drug-eluting stent era

David M. Safley, Steven P. Marso

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Diabetes mellitus has reached epidemic proportions and is associated with decreased event-free survival following coronary revascularization. Although the historical complication rates for diabetic patients following percutaneous coronary intervention have been less than acceptable, the emerging drug-eluting stent technology when coupled with an aggressive adjunctive pharmacological regimen will improve the complication rates following percutaneous revascularization for this high-risk group of patients. This review will focus on the historical data associated with revascularization, percutaneous and surgical, and diabetes mellitus and will highlight the emerging data of drug-eluting stents and adjunctive pharmacology.

Original languageEnglish (US)
Pages (from-to)542-550
Number of pages9
Issue number5
StatePublished - Aug 1 2004


  • Coronary artery disease
  • Diabetes mellitus
  • Drug eluting stents
  • Percutaneous coronary revascularization

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Diabetes and percutaneous coronary revascularization in the drug-eluting stent era'. Together they form a unique fingerprint.

Cite this